Back to Trades
Friberg Gregory R
EVPChief R&D OfficerCIK 0002038768
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025–2026
Across 5 filings between 2025–2026, Friberg Gregory R, EVP, Chief R&D Officer, has disclosed $3.7M in transactions — all concentrated in BIOMARIN PHARMACEUTICAL INC (BMRN). Their disclosed trades are heavily weighted toward selling — $0 in buys and $558.6K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Oct 1 | BMRN BIOMARIN PHARMACEUTICAL INC | Friberg Gregory R | EVP, Chief R&D Officer | Tax withheld | $245.2K |
| May 11 | BMRN BIOMARIN PHARMACEUTICAL INC | Friberg Gregory R | EVP, Chief R&D Officer | Sell | $176.7K |
| Mar 18 | BMRN BIOMARIN PHARMACEUTICAL INC | Friberg Gregory R | EVP, Chief R&D Officer | Grant | $2.7M |
| Feb 26 | BMRN BIOMARIN PHARMACEUTICAL INC | Friberg Gregory R | EVP, Chief R&D Officer | Sell | $381.9K |
| Oct 2 | BMRN BIOMARIN PHARMACEUTICAL INC | Friberg Gregory R | EVP, Chief R&D Officer | Tax withheld | $178.9K |
5 filings